S'abonner

Unintentional pediatric poisonings before and during the COVID-19 pandemic: A population-based study - 19/01/24

Doi : 10.1016/j.ajem.2023.11.042 
Daniel T. Myran, MD a, b, c, d, , Adrienne Gaudreault, MPH a, Stephen D.S. McCarthy, MD, PhD a, Michael Pugliese, MSc c, Peter Tanuseputro, MD a, b, c, d, Yaron Finkelstein, MD e, f
a Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 
b Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada 
c ICES uOttawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 
d Bruyère Research Institute, Ottawa, Ontario, Canada 
e Divisions of Pediatric Emergency Medicine and Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada 
f Departments of Pediatrics and Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada 

Corresponding author at: Ottawa Hospital Research Institute, 1053 Carling Avenue, PO Box 693, Ottawa, ON K1Y 4E9, Canada.Ottawa Hospital Research Institute1053 Carling AvenuePO Box 693OttawaONK1Y 4E9Canada

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Objectives

The impact of coronavirus disease 2019 (COVID-19) on unintentional pediatric poisonings is unclear. We examined changes in emergency department (ED) visits and hospitalizations for poisonings before and during the COVID-19 pandemic. We compared changes in cannabis vs non-cannabis poisoning events given the recent legalization of cannabis in October 2018 and cannabis edibles in January 2020.

Study design

Interrupted time-series (ITS) analyses of changes in population-level ED visits and hospitalizations for poisonings in children aged 0–9 years in Ontario, Canada (annual population of 1.4 million children), over two time periods: pre-pandemic (January 2010–March 2020) and pandemic (April 2020–December 2021).

Results

Overall, there were 28,292 ED visits and 2641 hospitalizations for unintentional poisonings. During the pandemic, poisonings per 100,000 person-years decreased by 14.6% for ED visits (40.15 pre- vs. 34.29 during) and increased by 35.9% for hospitalizations (3.48 pre- vs. 4.73 during). ED visits dropped immediately (Incidence Rate Ratio [IRR], 0.76; 95% CI, 0.70–0.82) at the onset of the pandemic, followed by a gradual return to baseline (quarterly change, IRR 1.04, 95%CI 1.03–1.06), while hospitalizations had an immediate increase (IRR 1.34; 95% CI, 1.08–1.66) and no gradual change. The only increase in poisonings was for cannabis which had a 10.7-fold for ED visits (0.45 to 4.83 per 100,000 person-years) and a 12.1-fold increase for hospitalizations (0.16 to 1.91 per 100,000 person-years). Excluding cannabis, there was no overall increase in poisoning hospitalizations.

Conclusions

The COVID-19 pandemic was not associated with increases in any type of unintentional pediatric poisonings, with the exception of cannabis poisonings. Increased cannabis poisonings may be explained by the legalization of non-medical cannabis edibles in Canada in January 2020.

Le texte complet de cet article est disponible en PDF.

Highlights

Pediatric poisoning ED visits decreased by 14.6% in the COVID-19 pandemic.
Critically, the only increase in ED poisonings was a 10-fold increase from cannabis.
Pediatric poisoning hospitalizations increased by 35.9%.
Cannabis became the leading cause of pediatric hospitalization from poisonings.
Excluding cannabis there was no overall increase in hospitalization from poisoning.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Poisoning, Children, Pediatrics, cannabis, Legalization

Abbreviations and acronyms : CI, COVID-19, ED, ICD-10, IC/ES, ICU, IRR, ITS, NSAID


Plan


© 2023  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 76

P. 185-192 - février 2024 Retour au numéro
Article précédent Article précédent
  • Safety/booster seats in pediatric motor vehicle crashes: Public health concern
  • Jeffrey Santos, Areg Grigorian, Morgan Schellenberg, Kazuhide Matsushima, Jeffry Nahmias, Rebecca Barros, Kenji Inaba
| Article suivant Article suivant
  • Analysis of Patient Adherence to Filling Emergency Department Discharge Prescriptions for Empiric Treatment of Chlamydia
  • Ashley Jackson, Emily Kilber, Clinton Peter, Bikash Bhattarai

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.